Andrew Rappaport

Insider Reports History

Entity
Individual
Signature
/s/ Shane Kovacs, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Rappaport:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Olema Pharmaceuticals, Inc. Director Common Stock 386K $5.02M $13.00 Mar 5, 2024 Indirect
Olema Pharmaceuticals, Inc. Director Stock Option (right to buy) 23K Jun 14, 2024 Direct

Insider Reports Filed by Andrew Rappaport

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OLMA Olema Pharmaceuticals, Inc. Jun 14, 2024 1 $0 4 Jun 18, 2024 Director
OLMA Olema Pharmaceuticals, Inc. Mar 5, 2024 2 $0 4 Mar 6, 2024 Director
OLMA Olema Pharmaceuticals, Inc. Jun 16, 2023 1 $0 4 Jun 21, 2023 Director
OLMA Olema Pharmaceuticals, Inc. Jun 17, 2022 1 $0 4/A Jun 27, 2022 Director
OLMA Olema Pharmaceuticals, Inc. Jun 16, 2022 1 $0 4 Jun 17, 2022 Director
OLMA Olema Pharmaceuticals, Inc. Jun 9, 2021 1 $0 4 Jun 10, 2021 Director